Secondary Logo

Share this article on:

Assessing the Risks of Breast Implants and FDA's Vision for the National Breast Implant Registry

Ashar, Binita S., MD, MBA, FACS

doi: 10.1097/SLA.0000000000003052
Editorial: PDF Only

Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD.

Reprints: Binita S. Ashar, MD, MBA, FACS, Director, Division of Surgical Devices, Center for Devices and Radiological Health, US Food and Drug Administration, 10903 New Hampshire Avenue WO-66, Silver Spring, MD 20993. E-mail: binita.ashar@fda.hhs.gov.

The author reports no conflicts of interest.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.